{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:45:31Z","timestamp":1790109931605,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,20]],"date-time":"2020-09-20T00:00:00Z","timestamp":1600560000000},"content-version":"vor","delay-in-days":324,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aaceclinicalcasereports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Clinical Case Reports"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.4158\/accr-2019-0170","type":"journal-article","created":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T12:53:42Z","timestamp":1566996822000},"page":"e388-e392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pancytopenia and Lymphoid Organ Hyperplasia in a Patient with Graves Disease: Response to Antithyroid Drug Therapy"],"prefix":"10.1016","volume":"5","author":[{"given":"Jonathan C.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Nandiraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Jabbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan A.","family":"Kubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/ACCR-2019-0170_bb0010","article-title":"Atypical complications of Graves' disease: a case report and literature review","volume":"2017","author":"Baagar","year":"2017","journal-title":"Case Rep Endocrinol"},{"key":"10.4158\/ACCR-2019-0170_bb0015","doi-asserted-by":"crossref","DOI":"10.1177\/1179547618781090","article-title":"Graves disease causing pancytopenia: case report and literature review","volume":"11","author":"Pincet","year":"2018","journal-title":"Clin Med Insights Case Rep"},{"key":"10.4158\/ACCR-2019-0170_bb0020","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1365-2265.2008.03382.x","article-title":"Characterization of the anaemia associated with Graves' disease","volume":"70","author":"Gianoukakis","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/ACCR-2019-0170_bb0025","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/pgmj.64.756.735","article-title":"The haematology of hyperthyroidism: abnormalities of erythrocytes, leucocytes, thrombocytes and haemostasis","volume":"64","author":"Ford","year":"1988","journal-title":"Postgrad Med J"},{"key":"10.4158\/ACCR-2019-0170_bb0030","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1210\/jcem-40-2-211","article-title":"Erythropoiesis and erythropoietin in hypo- and hyperthyroidism","volume":"40","author":"Das","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/ACCR-2019-0170_bb0035","first-page":"347","article-title":"Grave's disease following aplastic anemia: predisposition or coincidence?","volume":"52","author":"Zhang","year":"2015","journal-title":"Indian Pediatr"},{"key":"10.4158\/ACCR-2019-0170_bb0040","first-page":"35","article-title":"The haematology of hyperthyroidism","volume":"47","author":"Nightingale","year":"1978","journal-title":"Q J Med"},{"key":"10.4158\/ACCR-2019-0170_bb0045","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/194542","article-title":"Graves' disease causing pancytopenia and autoimmune hemolytic anemia at different time intervals: a case report and a review of the literature","volume":"2013","author":"Naji","year":"2013","journal-title":"Case Rep Med"},{"key":"10.4158\/ACCR-2019-0170_bb0050","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2169\/internalmedicine.50.4319","article-title":"Successful remission of Evans syndrome associated with Graves' disease by using propylthiouracil monotherapy","volume":"50","author":"Ushiki","year":"2011","journal-title":"Intern Med"},{"key":"10.4158\/ACCR-2019-0170_bb0055","first-page":"1056","article-title":"Thrombocytopenia in Graves' disease [in German]","volume":"137","author":"Schmohl","year":"2012","journal-title":"Dtsch Med Wochenschr"},{"key":"10.4158\/ACCR-2019-0170_bb0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jca.21210","article-title":"Thrombotic thrombocytopenic purpura precipitated by thyrotoxicosis","volume":"27","author":"Chhabra","year":"2012","journal-title":"J Clin Apher"},{"key":"10.4158\/ACCR-2019-0170_bb0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000207396","article-title":"Thrombocytopenia in Graves' disease: effect of T3 on platelet kinetics","volume":"63","author":"Kurata","year":"1980","journal-title":"Acta Haematol"},{"key":"10.4158\/ACCR-2019-0170_bb0070","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/cen.13133","article-title":"Treatment of hyperthyroidism with antithyroid drugs corrects mild neutropenia in Graves' disease","volume":"85","author":"Aggarwal","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/ACCR-2019-0170_bb0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000206684","article-title":"Disorders of granulopoiesis in patients with untreated Graves' disease","volume":"70","author":"Ponassi","year":"1983","journal-title":"Acta Haematol"},{"key":"10.4158\/ACCR-2019-0170_bb0080","doi-asserted-by":"crossref","first-page":"e886","DOI":"10.1097\/MD.0000000000000886","article-title":"High frequency of thyroid disorders in patients presenting with neutropenia to an outpatient hematology clinic STROBE-compliant article","volume":"94","author":"Kyritsi","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.4158\/ACCR-2019-0170_bb0085","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1089\/thy.2017.0086","article-title":"Thymic hyperplasia associated with Graves' disease: pathophysiology and proposed management algorithm","volume":"27","author":"Haider","year":"2017","journal-title":"Thyroid"},{"key":"10.4158\/ACCR-2019-0170_bb0090","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3349\/ymj.2016.57.3.795","article-title":"Graves' patient with thymic expression of thyrotropin receptors and dynamic changes in thymic hyperplasia proportional to Graves' disease activity","volume":"57","author":"Song","year":"2016","journal-title":"Yonsei Med J"},{"key":"10.4158\/ACCR-2019-0170_bb0095","unstructured":"LJ.DeGrootGraves' disease and the manifestations of thyrotoxicosis. Endotext. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK285548\/. Accessed September 11, 2019."},{"key":"10.4158\/ACCR-2019-0170_bb0100","doi-asserted-by":"crossref","first-page":"904","DOI":"10.7326\/0003-4819-31-5-904","article-title":"Hepatosplenomegaly and liver damage in Graves' disease","volume":"31","author":"Wallerstein","year":"1949","journal-title":"Ann Intern Med"},{"key":"10.4158\/ACCR-2019-0170_bb0105","first-page":"104","article-title":"Graves' disease with splenomegaly and pancytopenia, mimicking B-cell lymphoproliferative disease [in Japanese]","volume":"49","author":"Ohtsuka","year":"2008","journal-title":"Rinsho Ketsueki"}],"container-title":["AACE Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S237606052030033X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S237606052030033X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:31:24Z","timestamp":1762497084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S237606052030033X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S237606052030033X"],"URL":"https:\/\/doi.org\/10.4158\/accr-2019-0170","relation":{},"ISSN":["2376-0605"],"issn-type":[{"value":"2376-0605","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pancytopenia and Lymphoid Organ Hyperplasia in a Patient with Graves Disease: Response to Antithyroid Drug Therapy","name":"articletitle","label":"Article Title"},{"value":"AACE Clinical Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/ACCR-2019-0170","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}